Impact of Temporary Percutaneous Mechanical Circulatory Support Before Transplantation in the 2018 Heart Allocation System

被引:29
作者
Clerkin, Kevin J. [1 ]
Salako, Oluwafeyijimi [1 ]
Fried, Justin A. [1 ]
Griffin, Jan M. [1 ]
Raikhelkar, Jayant [1 ]
Jain, Rashmi [1 ]
Restaino, Susan [1 ]
Colombo, Paolo C. [1 ]
Takeda, Koji [2 ]
Farr, Maryjane A. [1 ]
Sayer, Gabriel [1 ]
Uriel, Nir [1 ]
Topkara, Veli K. [1 ]
机构
[1] Columbia Univ, Vagelos Coll Phys & Surg, Dept Med, Milstein Div Cardiol, New York, NY 10032 USA
[2] Columbia Univ, Vagelos Coll Phys & Surg, Dept Surg, Div Cardiac Surg, New York, NY 10032 USA
关键词
2018 allocation policy; heart transplant; mechanical circulatory support; outcomes; UNOS;
D O I
10.1016/j.jchf.2021.08.003
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVES This analysis sought to investigate the waitlist and post-transplant outcomes of individuals bridged to transplantation by using temporary percutaneous endovascular mechanical circulatory support (tMCS) through a status 2 designation (cardiogenic shock and exception). BACKGROUND The 2018 donor heart allocation policy change granted a status 2 designation to patients supported with tMCS. METHODS Adult patients in the United Network for Organ Sharing registry after October 18, 2018 who received a status 2 designation for tMCS were included and grouped by their status 2 criteria: cardiogenic shock with hemodynamic criteria (CS-HD), cardiogenic shock without hemodynamic criteria before tMCS (CS-woHD), and exception. Baseline characteristics, waitlist events (death and delisting), and post-transplant outcomes were compared. RESULTS A total of 2,279 patients met inclusion criteria: 68.6% (n =1,564) with CS-HD, 3.2% (n = 73) with CS-woHD, and 28.2% (n = 642) with exceptions. A total of 64.2% of patients underwent heart transplantation within 14 days of status 2 listing or upgrade, and 1.9% died or were delisted for worsening clinical condition. Among the 35.8% who did not undergo transplantation following 14 days, only 2.8% went on to receive a left ventricular assist device (LVAD). The 30-day transplantation likelihood was similar among groups: 80.1% for the CS-HD group vs 79.7% for the exception group vs 73.3% for the CS-woHD group; P = 0.31. However, patients who met criteria for CS-woHD had 2.3-fold greater risk of death or delisting (95% CI: 1.10-4.75; P = 0.03) compared with CS-HD patients after multivariable adjustment. Pre-tMCS hemodynamics were not associated with adverse waitlist events. CONCLUSIONS The use of tMCS is an efficient, safe, and effective strategy as a bridge to transplantation; however, patients with CS-woHD may represent a high-risk cohort. Transition to a durable LVAD was a rare event in this group. (J Am Coll Cardiol HF 2022;10:12-23) (c) 2022 by the American College of Cardiology Foundation.
引用
收藏
页码:12 / 23
页数:12
相关论文
共 11 条
[11]   Exception Status Listing in the New Adult Heart Allocation System A New Solution to an Old Problem? [J].
Topkara, Veli K. ;
Clerkin, Kevin J. ;
Fried, Justin A. ;
Griffin, Jan ;
Raikhelkar, Jayant ;
Lee, Sun Hi ;
Latif, Farhana ;
Habal, Marlena ;
Horn, Evelyn ;
Farr, Maryjane A. ;
Takada, Koji ;
Naka, Yoshifumi ;
Jorde, Ulrich P. ;
Sayer, Gabriel ;
Uriel, Nir .
CIRCULATION-HEART FAILURE, 2021, 14 (06) :E007916